Suppr超能文献

与HIV-1无关的CD8 + 细胞毒性T淋巴细胞对HIV-1复制的抑制作用导致体外持续感染HIV-1的细胞得以保存。

Suppression of HIV-1 replication by HIV-1-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-1-infected cells in vitro.

作者信息

Liu Huining, Ohashi Takashi, Masuda Takao, Zhou Xin, Kubo Makoto, Kannagi Mari

机构信息

Department of Immunotherapeutics, Medical Research Division, Tokyo Medical and Dental University, Tokyo, Japan.

出版信息

Viral Immunol. 2003;16(3):381-93. doi: 10.1089/088282403322396172.

Abstract

CD8+ cells of asymptomatic HIV-1 carriers (AC) contain HIV-1-specific cytotoxic T lymphocytes (CTLs) but suppress HIV-1 replication in a class I major histocompatibility complex (MHC-I)-unrestricted manner. In order to selectively investigate the HIV-1-suppressive function of CTLs apart from HIV-1-specific cytotoxicity, HIV-1-irrelevant allo-specific CTLs were established from an HIV-1-uninfected individual and their HIV-1-suppressive activity against autologous CD4+ peripheral blood mononuclear cells (PBMC) was examined. We found that these CTLs significantly suppressed both R5 and X4-HIV-1 replication in either acutely or persistently infected autologous PBMC. Although these CTLs partially killed HIV-1-infected PBMC through Fas ligand, CTLs still suppressed late steps of HIV-1 replication in the presence of neutralizing antibodies to Fas ligand. HIV-1 replication in PBMC that had been suppressed by CTLs was reversible following depletion of CTLs from culture, analogous to the previous observation for CD8+ cell-depleted PBMC of AC. Induction of HIV-1 replication by CTL-depletion was amplified by addition of newly prepared CD4+ cells or activation with staphylococcal enterotoxin B. Our results indicate that CTLs can suppress HIV-1 replication in PBMC in an antigen-nonspecific manner and preserve infected cells in a state capable of restarting HIV-1 replication and transmission.

摘要

无症状HIV-1携带者(AC)的CD8 +细胞含有HIV-1特异性细胞毒性T淋巴细胞(CTL),但以I类主要组织相容性复合体(MHC-I)非限制性方式抑制HIV-1复制。为了选择性研究CTL的HIV-1抑制功能,而不考虑HIV-1特异性细胞毒性,从一名未感染HIV-1的个体中建立了与HIV-1无关的同种异体特异性CTL,并检测了它们对自体CD4 +外周血单核细胞(PBMC)的HIV-1抑制活性。我们发现,这些CTL在急性或持续感染的自体PBMC中均能显著抑制R5和X4-HIV-1的复制。尽管这些CTL通过Fas配体部分杀伤HIV-1感染的PBMC,但在存在Fas配体中和抗体的情况下,CTL仍能抑制HIV-1复制的后期步骤。CTL抑制后的PBMC中的HIV-1复制在从培养物中去除CTL后是可逆的,这与之前对AC的CD8 +细胞耗竭的PBMC的观察结果类似。通过添加新制备的CD4 +细胞或用葡萄球菌肠毒素B激活,可增强CTL耗竭诱导的HIV-1复制。我们的结果表明,CTL可以以抗原非特异性方式抑制PBMC中的HIV-1复制,并使感染细胞保持在能够重新启动HIV-1复制和传播的状态。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验